Search

Your search keyword '"Svegliati Baroni, Gianluca"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Svegliati Baroni, Gianluca" Remove constraint Author: "Svegliati Baroni, Gianluca" Database ScienceDirect Remove constraint Database: ScienceDirect
40 results on '"Svegliati Baroni, Gianluca"'

Search Results

1. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study

2. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care

3. Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

5. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

6. A global research priority agenda to advance public health responses to fatty liver disease

7. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

8. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

9. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

10. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

12. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

14. WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease

15. THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab

16. SAT-477-YI The impact of etiologyon patterns of progression of advanced HCC

17. THU-161 Hepatic sarcoidosis diagnosis and management: an italian multicenter study

18. Global multi-stakeholder endorsement of the MAFLD definition

22. SAT-430 - Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interim analysis of an Italian prospective multicentre study

23. THU-421 - Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced non-alcoholic fatty liver disease

24. THU-527 - Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy

25. LBP-09 - Further decompensation as a new prognostic stage in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements

26. OS-069 - Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy

27. Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)” [Dig Liver Dis 54 (2022) 170–182]

Catalog

Books, media, physical & digital resources